Objectives This prospective study aims to evaluate the outcomes and safety of Ultrasound Cycloplasty(UCP) in controlling intraocular pressure in patients with prior failed glaucoma surgeries.

Methods A total of 20 eyes from 19 patients who underwent UCP following failed glaucoma surgery between September 2020 to September 2022, were included. All patients were followed for over 12 months. Intraocular pressure, ocular hypotensive medications, and best-corrected visual acuity were recorded and compared after surgery. Complete success was defined as intraocular pressure within the range of 6-21mmHg after treatment, without the use of anti-glaucoma agents. Qualified success was defined the same as complete success but allows the presence of anti-glaucoma agents.

Results At 12 months follow-up, intraocular pressure decreased from 45.10±10.74 mmHg to 20.80±6.05 mmHg, representing a reduction of 53.88% (P < 0.01). The rates of complete successes and qualified successes were 20.00% (4 of 20 eyes) and 65.00% (13 of 20 eyes) 12 months after treatment respectively.

Conclusion UCP is a safe and effective surgical approach for eyes with prior failed glaucoma surgeries.

The authors have declared no competing interest.

Yes

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Not Applicable

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Ethics Committee of Nanchang First Hospital, JiangXi, China

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Not Applicable

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Not Applicable

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Not Applicable

Data cannot be shared publicly because of patient's Privacy. Data are available from the Nanchang First Hospital (contact via Liu Li) for researchers who meet the criteria for access to confidential data.